Expectations have been raised by the Oxford University’s Corona Vaccine AZD1222. Many countries in Europe are helping Oxford to make this vaccine trial a success. According to a Washington Post report, it is probably the only vaccine that can be declared successful by the end of this year.
AZD1222 vaccine results have been good in trials conducted on beginners and less people. Thousands of people are being vaccinated in large trials, whose results are yet to come. Vaccine supplements for large trials were produced by the Advent company in Rome, Italy.
According to the report, the countries of Europe are in the front line of Oxford University for the AZD1222 vaccine. Only last week, Italy, Germany, France and the Netherlands signed a deal for 40 million doses of the Oxford vaccine. After a large trial, if the vaccine is approved by the government agencies, then AstraZeneca will produce millions of doses in a very short time. The United States and Britain have tied up with this company.
The special thing is that the Oxford University’s Coronavirus vaccine AZD1222 is far ahead of other vaccine candidates. This vaccine is being manufactured in many countries including India. Many countries of the west are considering this vaccine best.
Get real time update about this post categories directly on your device, subscribe now.